Source - SMW
BOS  GLOBAL Holdings NL has issued an update  on its operations.

BOS  has  appointed its wholly-owned subsidiary BOS Distributions Pty as the  licensee  for  the purposes  of promoting, marketing, distributing, reproducing, supplying and publishing the Kronologica  and Meetingly  products  to  third party end users with effect from 12 Septembe, replacing  the  previous licensee Hostisme Pty Ltd (a 50:50 JV company).

BOS has also announced it has appointed Dr Luke Strotz as chief scientific adviser to BOS GLOBAL Holdings  NL.  

Strotz's  field  of study in Bio Science will offer a  unique  perspective  towards  the collection  of  workplace data as well as valuable insights into the dynamics of workplace communities.  

Strotz  will advise the BOS-360 Work Patterns team on the development of a purpose built taxonomy (a system for classifying data). This taxonomy will become the foundation of the BOS360 Platform as a Service (PaaS).

1,075,200  fully paid ordinary shares have been allotted to Capresi Consolidated Limited for the  provision of  advisory services in relation to the  company's readmission to AIM. Application has also been  made  for these  shares to be admitted to trading on AIM on or around 21 September 2016. 

Following admission  of  the shares, BOS will have 51,075,198 fully paid ordinary shares in issue.

The company has also granted 500,000 warrants to RFC Ambrian Limited under  the terms of their engagement agreement. The warrants expire on 30 August 2021 and have an  exercise price of 10.4 pence.

Finally, shareholders are advised that the new corporate website for BOS is now live. The address  for  the new website is